NCT00527917View on ClinicalTrials.gov

A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Interstitial Cystitis
Interventions
DEVICE

placebo

bladder instillation

DEVICE

Uracyst

20 ml sterile solution for weekly intravesical instillation

Trial Locations (13)

Unknown

Surrey

Vancouver

Victoria

Kentville

Barrie

Brantford

Guelph

Kingston

Kitchener

Newmarket

North Bay

Thunder Bay

Toronto

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00527917 - A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. | Biotech Hunter | Biotech Hunter